“People with mental illness are a medically-underserved population and, fueled by my passion, I aim to contribute and be an agent of change in this field; this is the purpose of my private practice.”
What was your path to becoming a Psychiatric Nurse Practitioner?
Prior to becoming a psych NP, I worked as a staff reporter for an entertainment magazine. After several years, I found myself gravitating toward work that allowed me to directly serve others in a meaningful way. While volunteering at hospitals and other nonprofit organizations, I fell in love with the holistic and hands-on way that nurses helped people who often were in difficult and vulnerable stages of their lives. In nursing school, I was organically drawn toward psychiatry as I believe mental wellness to be as essential as air in terms of one's quality of life and yet it is a discipline that is often misunderstood and stigmatized. People with mental illness are a medically-underserved population and, fueled by my passion, I aim to contribute and be an agent of change in this field; this is the purpose of my private practice.
What should someone know about working with you?
Although I am currently only providing medication management, I am a strong proponent of talk therapy. My ideal client is one who is interested in both psychotherapy and psychotropic medications and is willing to do the required work in the circuitous journey toward mental wellness.
What do you do to continue learning and building competencies as a provider?
In addition to completing a minimum of 100 hours a year of category 1 CME credits for healthcare providers, I also engage in self-study by reading the latest scholarly journals in psychiatry and books discussing new breakthroughs in this field. As a clinical professor and an attending NP at NYU Langone Health and Bellevue Hospital — two renowned institutions in academia and in the field of psychiatry — I am also privy to cutting-edge research and am fortunate to have access to and the opportunity to collaborate with some of the best and brightest clinicians in the mental health field.
What are you most excited about within the evolving mental health landscape?
I am really excited about the recent momentum in the search for new treatment options for people with mental illness. Compared to other specialties, like cardiology or oncology, psychiatry has largely been overlooked by researchers, pharmaceutical companies, and government agencies, resulting in a lag of novel treatment since the advent of SSRI/SNRIs and second-generation antipsychotics. Fortunately, this appears to be changing. In 2019, the FDA approved esketamine nasal spray, and there are currently exciting new therapies being studied in psychiatry, including the use of LSD therapy for depression and the investigation into the relationship among gut microbiota, inflammation, and mental illness. Although the research is still in its infancy, I am nevertheless glad for this fresh burst of energy and I look forward to experiencing the next phase of evolution in the field of psychiatry.
“My ideal client is one who is interested in both psychotherapy and psychotropic medications and is willing to do the required work in the circuitous journey toward mental wellness.”